Alpha 2.0
Login Register
» Authors » A Gambardella

A Gambardella

Explore the profile of A Gambardella including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 279
Citations 2177
Followers 0
Related Specialties
Neurology
Infectious Diseases
Radiology
Top 10 Co-Authors
A Quattrone
U Aguglia
G Paolisso
M Varricchio
M Zappia
R L Oliveri
P Valentino
A Labate
M R Tagliamonte
F Bono
Published In
Acta Med Ital Mal Infett Parassit
Neurology
Radiol Med
Epilepsia
Acta Neurol (Napoli)
Affiliations
Soon will be listed here.
Recent Articles
1.
Hereditary Spastic Paraplegia Associated with Ultra-Rare Variant Enrichment Encompassing the SYNE1, CAPN1 and PGAP1 Genes
Fratto E, Morelli M, Buonocore J, Quattrone A, Procopio R, Gagliardi M, et al.
Cerebellum . 2024 Dec; 24(1):3. PMID: 39641820
No abstract available.
2.
Efficacy, safety and patient's satisfaction for treatment of genital psoriasis with tildrakizumab: a case series and review of literature
Licata G, Danzuso G, Fiorella C, Palazzo G, Calzavara-Pinton P, Argenziano G, et al.
J Eur Acad Dermatol Venereol . 2022 Jun; 36(11):e916-e918. PMID: 35758324
No abstract available.
3.
Is itching in atopic dermatitis still an unmet need? A case series of 556 patients
Tancredi V, Licata G, Calabrese G, Gambardella A, De Rosa A, Alfano R, et al.
J Eur Acad Dermatol Venereol . 2022 Mar; 36(8):e650-e652. PMID: 35353939
No abstract available.
4.
Clinical improvement of atopic dermatitis in two patients co-affected with non-severe COVID-19 infection: A case series and review of literature
Licata G, Buononato D, Fiorentino C, Calabrese G, De Rosa A, Argenziano G, et al.
J Eur Acad Dermatol Venereol . 2022 Jan; 36(5):e339-e341. PMID: 35015918
No abstract available.
5.
Face atopic dermatitis resistant to dupilumab: a case series of three patients successfully treated with upadacitinib
Licata G, Gambardella A, Tancredi V, Calabrese G, De Rosa A, Alfano R, et al.
J Eur Acad Dermatol Venereol . 2021 Sep; 36(2):e150-e152. PMID: 34553800
No abstract available.
6.
Aarskog-Scott syndrome and atopic dermatitis successfully treated with dupilumab: a casual presentation?
Calabrese G, Licata G, Buononato D, Gambardella A, De Rosa A, Argenziano G
Clin Exp Dermatol . 2021 Sep; 47(2):452-453. PMID: 34482546
No abstract available.
7.
Refractory Type I pityriasis rubra pilaris treated with tildrakizumab
Licata G, Gambardella A, Calabrese G, Pagliuca F, Alfano R, Argenziano G
Clin Exp Dermatol . 2021 Jun; 46(8):1594-1595. PMID: 34101231
No abstract available.
8.
Dupilumab and conjunctivitis: a case series of twenty patients
Calabrese G, Gambardella A, Licata G, Di Brizzi E, Alfano R, Argenziano G
J Eur Acad Dermatol Venereol . 2021 Mar; 35(9):e612-e614. PMID: 33657247
No abstract available.
9.
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab
Rapisarda L, Valentino P, Barone S, Torti C, La Gamba V, Fortunato F, et al.
Clin Immunol . 2020 Aug; 223:108554. PMID: 32777270
Ocrelizumab is a novel humanized anti-CD20 antibody used for treatment of relapsing remitting and primary progressive multiple sclerosis with evidence of inflammatory activity. Guidelines suggest assessing vaccination status and eventually...
10.
Assessing conformal thin film growth under nonstochastic deposition conditions: application of a phenomenological model of roughness replication to synthetic topographic images
Bontempi M, Visani A, Benini M, Gambardella A
J Microsc . 2020 Jul; 280(3):270-279. PMID: 32691852
In this work, a simple method to follow the evolution of the surface of thin films during growth on substrates characterised by high roughness is detailed. To account for real...